For nearly a year we’ve been living with the new realities created by the COVID-19 pandemic. Even as scientists and medical professionals are uncovering new facts about the virus, we’re still faced with many questions. Once we have an approved effective vaccine, who will have access to it? How much will it cost? How will we adapt to ensure the vaccine makes it to those most in need?
For more than 20 years, the Access Campaign has worked to change government policies and pharmaceutical industry practices to ensure that effective drugs, tests, and vaccines are available, affordable, and suitable for the people who need them most. In the time of COVID-19, the whole world is experiencing the consequences of a vaccine and medicines development system that places profits before people. The time for systemic reforms has never been more vital.
Join Doctors Without Borders/Médecins Sans Frontières (MSF) for this critical final discussion in our fall Let’s Talk webinar series on November 12. We’ll be in conversation with Dana Gill, U.S. policy advisor on access to medicines for MSF-USA and the Access Campaign, and Manuel Martin, medical innovation & access policy advisor for the Access Campaign based in Geneva. Together with our host, MSF-USA executive director Avril Benoît, this expert panel will answer your questions about a COVID-19 vaccine and the road to ensuring access to essential medicines to all in need.
Read more about MSF’s Access Campaign at
Make sure you don’t miss weekly video updates and ongoing series about our work in crisis zones across the world. Subscribe to our channel here:
Doctors Without Borders/Médecins Sans Frontières helps people worldwide where the need is greatest, delivering emergency medical aid to people affected by conflict, epidemics, disasters, or exclusion from health care. Learn more at
SUBSCRIBE:
Like us on Facebook:
Follow us on Instagram:
Follow us on Twitter:
Connect with us on LinkedIn:
Sign up for our newsletter:
